Targeting colon and kidney

Pathophysiological determinants of design strategy

Ajit S. Narang, Ram I Mahato

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

Targeted drug delivery to an organ or tissue is intended to bring the drug to its primary site of action. Thus, it can help improve the efcacy of the drug or prevent its undesired toxicities in other tissues or organs. In addition, sometimes targeted strategies are intended to avoid drug exposure to a specic organ or tissue. This can help avoid specic drug-related toxicities, increase systemic exposure, and achieve higher concentration at the target site. Most targeted drug delivery systems involve the use of macromolecular or particulate carriers, with the aim of modifying the pharmacokinetics and cellular distribution of the drug. In addition to achieving higher drug concentrations and/or prolonged exposure within the target cells, strategies can be designed to target organelles or specic compartments within the target cells. The overall goal of all drug-targeting strategies is the improvement of the efcacy and/or safety prole of a drug substance.

Original languageEnglish (US)
Title of host publicationTargeted Delivery of Small and Macromolecular Drugs
PublisherCRC Press
Pages351-370
Number of pages20
ISBN (Electronic)9781420087734
ISBN (Print)9781420087727
DOIs
StatePublished - Jan 1 2010

Fingerprint

Colon
Kidney
Pharmaceutical Preparations
Drug Delivery Systems
Drug-Related Side Effects and Adverse Reactions
Organelles
Pharmacokinetics
Safety

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Narang, A. S., & Mahato, R. I. (2010). Targeting colon and kidney: Pathophysiological determinants of design strategy. In Targeted Delivery of Small and Macromolecular Drugs (pp. 351-370). CRC Press. https://doi.org/10.1201/9781420087734

Targeting colon and kidney : Pathophysiological determinants of design strategy. / Narang, Ajit S.; Mahato, Ram I.

Targeted Delivery of Small and Macromolecular Drugs. CRC Press, 2010. p. 351-370.

Research output: Chapter in Book/Report/Conference proceedingChapter

Narang, AS & Mahato, RI 2010, Targeting colon and kidney: Pathophysiological determinants of design strategy. in Targeted Delivery of Small and Macromolecular Drugs. CRC Press, pp. 351-370. https://doi.org/10.1201/9781420087734
Narang AS, Mahato RI. Targeting colon and kidney: Pathophysiological determinants of design strategy. In Targeted Delivery of Small and Macromolecular Drugs. CRC Press. 2010. p. 351-370 https://doi.org/10.1201/9781420087734
Narang, Ajit S. ; Mahato, Ram I. / Targeting colon and kidney : Pathophysiological determinants of design strategy. Targeted Delivery of Small and Macromolecular Drugs. CRC Press, 2010. pp. 351-370
@inbook{8b98a57279664b65a6b1a324b078c498,
title = "Targeting colon and kidney: Pathophysiological determinants of design strategy",
abstract = "Targeted drug delivery to an organ or tissue is intended to bring the drug to its primary site of action. Thus, it can help improve the efcacy of the drug or prevent its undesired toxicities in other tissues or organs. In addition, sometimes targeted strategies are intended to avoid drug exposure to a specic organ or tissue. This can help avoid specic drug-related toxicities, increase systemic exposure, and achieve higher concentration at the target site. Most targeted drug delivery systems involve the use of macromolecular or particulate carriers, with the aim of modifying the pharmacokinetics and cellular distribution of the drug. In addition to achieving higher drug concentrations and/or prolonged exposure within the target cells, strategies can be designed to target organelles or specic compartments within the target cells. The overall goal of all drug-targeting strategies is the improvement of the efcacy and/or safety prole of a drug substance.",
author = "Narang, {Ajit S.} and Mahato, {Ram I}",
year = "2010",
month = "1",
day = "1",
doi = "10.1201/9781420087734",
language = "English (US)",
isbn = "9781420087727",
pages = "351--370",
booktitle = "Targeted Delivery of Small and Macromolecular Drugs",
publisher = "CRC Press",

}

TY - CHAP

T1 - Targeting colon and kidney

T2 - Pathophysiological determinants of design strategy

AU - Narang, Ajit S.

AU - Mahato, Ram I

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Targeted drug delivery to an organ or tissue is intended to bring the drug to its primary site of action. Thus, it can help improve the efcacy of the drug or prevent its undesired toxicities in other tissues or organs. In addition, sometimes targeted strategies are intended to avoid drug exposure to a specic organ or tissue. This can help avoid specic drug-related toxicities, increase systemic exposure, and achieve higher concentration at the target site. Most targeted drug delivery systems involve the use of macromolecular or particulate carriers, with the aim of modifying the pharmacokinetics and cellular distribution of the drug. In addition to achieving higher drug concentrations and/or prolonged exposure within the target cells, strategies can be designed to target organelles or specic compartments within the target cells. The overall goal of all drug-targeting strategies is the improvement of the efcacy and/or safety prole of a drug substance.

AB - Targeted drug delivery to an organ or tissue is intended to bring the drug to its primary site of action. Thus, it can help improve the efcacy of the drug or prevent its undesired toxicities in other tissues or organs. In addition, sometimes targeted strategies are intended to avoid drug exposure to a specic organ or tissue. This can help avoid specic drug-related toxicities, increase systemic exposure, and achieve higher concentration at the target site. Most targeted drug delivery systems involve the use of macromolecular or particulate carriers, with the aim of modifying the pharmacokinetics and cellular distribution of the drug. In addition to achieving higher drug concentrations and/or prolonged exposure within the target cells, strategies can be designed to target organelles or specic compartments within the target cells. The overall goal of all drug-targeting strategies is the improvement of the efcacy and/or safety prole of a drug substance.

UR - http://www.scopus.com/inward/record.url?scp=84866737789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866737789&partnerID=8YFLogxK

U2 - 10.1201/9781420087734

DO - 10.1201/9781420087734

M3 - Chapter

SN - 9781420087727

SP - 351

EP - 370

BT - Targeted Delivery of Small and Macromolecular Drugs

PB - CRC Press

ER -